VALSARTAN Side Effects

7005012-X | Anaemia Macrocytic, Benign Prostatic Hyperplasia, Escherichia Urinary Tract Infection, Hypertension, Metabolic Acidosis, Obstructive Uropathy, Oedema Peripheral, Renal Failure Acute, Skin Chapped
on Sep 20, 2010 Male patient from UNITED STATES , 62 years of age, weighting 191.8 lb, was diagnosed with hypertension, pain (What is pain?) and was treated with Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia macrocytic, benign prostatic hyperplasia, escherichia urinary tract infection, hypertension, metabolic acidosis, obstructive uropathy, oedema peripheral, renal failure acute, skin chapped. Valsartan dosage: 160 Mg Every Day Po. During the same period patient was treated with ETODOLAC (400 Mg Tid Po) (View Etodolac Review and Etodolac Label ). Patient was hospitalized.

6938254-X | Oligohydramnios, Premature Labour
Patient was taking Valsartan (View Usage). Patient had the following side effects: oligohydramnios, premature labour on Aug 10, 2010 from SPAIN Additional patient health information: Female patient , 44 years of age, was diagnosed with hypertension and. Valsartan dosage: . Patient was hospitalized.

6923477-6 | Oligohydramnios, Premature Baby, Pulmonary Hypoplasia, Renal Dysplasia, Renal Failure, Respiratory Failure
Adverse event was reported on Aug 10, 2010 by a Female patient taking Valsartan (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: SPAIN , weighting 5.56 lb, After Valsartan was administered, patient had the following side effects: oligohydramnios, premature baby, pulmonary hypoplasia, renal dysplasia, renal failure, respiratory failure.

6905996-1 | Cardiomyopathy, Chest Pain, Dizziness, Dyspnoea, Ejection Fraction Decreased, Mitral Valve Incompetence, Myocarditis
on Jul 21, 2010 Female patient from UNITED STATES , 40 years of age, was treated with Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?), chest pain (What is chest pain?), dizziness (What is dizziness?), dyspnoea, ejection fraction decreased, mitral valve incompetence, myocarditis. Valsartan dosage: 80 Mg Daily. During the same period patient was treated with FUROSEMIDE (20 Mg Daily) (View Furosemide Review and Furosemide Label ), CARVEDILOL (12.5 Mg, Bid) (View Carvedilol Review and Carvedilol Label ), TRAZODONE (50 Mg Daily) (View Trazodone Review and Trazodone Label ), CITALOPRAM (20 Mg Daily) (View Citalopram Review and Citalopram Label ). Patient was hospitalized.


6843996-0 | Angioedema, Blood Glucose Abnormal
on Jul 14, 2010 Male patient from UNITED STATES , 72 years of age, weighting 231.5 lb, was diagnosed with hypertension and was treated with Valsartan (View Usage). Patient had the following side effects: angioedema, blood glucose abnormal. Valsartan dosage: 320 Mg Daily Po, Prior To Admit. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), NOVOLOG (View Novolog Review and Novolog Label ), DETEMIR INSULIN (View Detemir Insulin Review and Detemir Insulin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DUTASTERIDE (View Dutasteride Review and Dutasteride Label ). Patient was hospitalized.

6800670-4 | Hypertensive Crisis
Patient was taking Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: hypertensive crisis on Jun 15, 2010 from SPAIN Additional patient health information: Male patient , 49 years of age, was diagnosed with hypertension, arthralgia and. Valsartan dosage: 80 Mg, Qd. During the same period patient was treated with DICLOFENAC SODIUM (50 Mg, Tid) (View Diclofenac Sodium Review and Diclofenac Sodium Label ).

6684297-3 | Adrenal Adenoma, Adrenalectomy, Angioplasty, Blood Aldosterone Increased, Blood Pressure Inadequately Controlled, Hypertension, Kidney Small, Primary Hyperaldosteronism, Renal Artery Stenosis
Adverse event was reported on Apr 05, 2010 by a Female patient taking Valsartan (View Usage) (Dosage: 80 Mg Per Day) was diagnosed with hypertension and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: adrenal adenoma, adrenalectomy, angioplasty (What is angioplasty?), blood aldosterone increased, blood pressure inadequately controlled, hypertension, kidney small, primary hyperaldosteronism, renal artery stenosis. During the same period patient was treated with NIFEDIPINE (40 Mg Per Day) (View Nifedipine Review and Nifedipine Label ), BUNAZOSIN (6 Mg Per Day) (View Bunazosin Review and Bunazosin Label ), ATENOLOL (50 Mg Per Day) (View Atenolol Review and Atenolol Label ).

6650283-2 | Abortion Induced, Accelerated Idioventricular Rhythm, Acute Myocardial Infarction, Blood Creatine Phosphokinase Mb Increased, Chest Pain, Nausea, Vascular Occlusion
on Dec 07, 2009 Female patient from KOREA, REPUBLIC OF , 44 years of age, was diagnosed with hypertension and was treated with Valsartan (View Usage). Patient had the following side effects: abortion induced, accelerated idioventricular rhythm, acute myocardial infarction, blood creatine phosphokinase mb increased, chest pain (What is chest pain?), nausea (What is nausea?), vascular occlusion. Valsartan dosage: . During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), MISOPROSTOL (200 Mg) (View Misoprostol Review and Misoprostol Label ), SULPROSTONE (42 Ug/hour) (View Sulprostone Review and Sulprostone Label ). Patient was hospitalized.

6644652-4 | Renal Failure Acute
on Mar 19, 2010 Male patient from UNITED STATES , 70 years of age, weighting 262.4 lb, was treated with Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: renal failure acute. Valsartan dosage: 80 Mg Every Day Po. Patient was hospitalized.

6593144-X | Anion Gap Increased, Blood Calcium Increased, Blood Creatinine Increased, Blood Phosphorus Increased, Bradycardia, Carbon Dioxide Decreased, Haemodialysis, Hyperkalaemia, Hypovolaemia
Patient was taking Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: anion gap increased, blood calcium increased, blood creatinine increased, blood phosphorus increased, bradycardia, carbon dioxide decreased, haemodialysis, hyperkalaemia, hypovolaemia on Feb 09, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, . Valsartan dosage: 160 Mg Daily. During the same period patient was treated with LOSARTAN POTASSIUM (50 Mg Daily) (View Losartan Potassium Review and Losartan Potassium Label ), LISINOPRIL (5 Mg Daily) (View Lisinopril Review and Lisinopril Label ), TACROLIMUS (Unk) (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6588084-6 | Angioedema
Adverse event was reported on Feb 17, 2010 by a Male patient taking Valsartan (View Usage) (Dosage: 160 Mg Every Day Po) was diagnosed with hypertension and. Location: UNITED STATES , 56 years of age, Patient had the following side effects: angioedema. Patient was hospitalized.

6577711-5 | Anxiety, Dizziness, Hypertension, Nausea, Orthostatic Hypotension, Somnolence, Vertebrobasilar Insufficiency
on Feb 11, 2010 Female patient from ARGENTINA , weighting 162.0 lb, was diagnosed with glucose tolerance impaired, hypertension, anxiety (What is anxiety?) and was treated with Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: anxiety (What is anxiety?), dizziness (What is dizziness?), hypertension, nausea (What is nausea?), orthostatic hypotension, somnolence, vertebrobasilar insufficiency. Valsartan dosage: Level 1. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6532819-5 | Abortion Induced, Accelerated Idioventricular Rhythm, Acute Myocardial Infarction, Blood Creatine Phosphokinase Mb Increased, Chest Pain, Nausea, Vascular Occlusion
on Dec 07, 2009 Female patient from KOREA, REPUBLIC OF , 44 years of age, was diagnosed with hypertension and was treated with Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced, accelerated idioventricular rhythm, acute myocardial infarction, blood creatine phosphokinase mb increased, chest pain (What is chest pain?), nausea (What is nausea?), vascular occlusion. Valsartan dosage: . During the same period patient was treated with CARVEDILOL (View Carvedilol Review and Carvedilol Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), MISOPROSTOL (200 Mg) (View Misoprostol Review and Misoprostol Label ), SULPROSTONE (42 Ug/hour) (View Sulprostone Review and Sulprostone Label ). Patient was hospitalized.

6526703-0 | Disorientation, Fall, Hallucination, Injury, Malaise, Osteoarthritis, Urinary Retention
Patient was taking Valsartan (View Usage). Patient had the following side effects: disorientation, fall (What is fall?), hallucination, injury, malaise, osteoarthritis (What is osteoarthritis?), urinary retention on Dec 22, 2009 from UNITED STATES Additional patient health information: Female patient , 87 years of age, was diagnosed with bladder cancer (What is bladder cancer?) and. Valsartan dosage: Intravesical. During the same period patient was treated with VESICARE (View Vesicare Review and Vesicare Label ), ENABLEX (DARIFENACIN) (View Enablex (darifenacin) Review and Enablex (darifenacin) Label ), MACROBID (View Macrobid Review and Macrobid Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), EFFEXOR (VENLAFAXINE) (VENLAFAXINE) (View Effexor (venlafaxine) (venlafaxine) Review and Effexor (venlafaxine) (venlafaxine) Label ), TOPROL (METOPROLOL SUCCINATE) (METOPROLOL SUCCINATE) (View Toprol (metoprolol Succinate) (metoprolol Succinate) Review and Toprol (metoprolol Succinate) (metoprolol Succinate) Label ), CARBOLERO (View Carbolero Review and Carbolero Label ), VITAMIN E (TOCOPHEROL) (TOCOPHEROL) (View Vitamin E (tocopherol) (tocopherol) Review and Vitamin E (tocopherol) (tocopherol) Label ).

6515525-2 | Acute Abdomen, Acute Coronary Syndrome, Anaemia, Angina Pectoris, Asthenia, Atrial Fibrillation, Carotid Artery Disease, Chest Pain, Chest Tube Insertion
Adverse event was reported on Dec 21, 2009 by a Male patient taking Valsartan (View Usage) (Dosage: Level 1) was diagnosed with cardiovascular disorder, glucose tolerance impaired and. Location: ARGENTINA , weighting 189.4 lb, After Valsartan was administered, patient had the following side effects: acute abdomen, acute coronary syndrome, anaemia, angina pectoris, asthenia, atrial fibrillation (What is atrial fibrillation?), carotid artery disease (What is carotid artery disease?), chest pain (What is chest pain?), chest tube insertion. During the same period patient was treated with STARLIX (Level 1) (View Starlix Review and Starlix Label ). Patient was hospitalized.

6507335-7 | Asthenia, Dizziness, Nausea, Orthostatic Hypotension
on Dec 18, 2009 Female patient from SOUTH AFRICA , weighting 143.3 lb, was diagnosed with cardiovascular disorder, ischaemic heart disease prophylaxis, periarthritis and was treated with Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), nausea (What is nausea?), orthostatic hypotension. Valsartan dosage: Level 1. During the same period patient was treated with NATEGLINIDE (Level 2) (View Nateglinide Review and Nateglinide Label ), DISPRIN (Unk) (View Disprin Review and Disprin Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ). Patient was hospitalized.

6507299-6 | Cough, Pneumonia, Productive Cough, Renal Failure Chronic, Renal Impairment
on Dec 16, 2009 Male patient from CHINA , weighting 135.4 lb, was diagnosed with cardiovascular disorder and was treated with Valsartan (View Usage). Patient had the following side effects: cough, pneumonia (What is pneumonia?), productive cough, renal failure chronic, renal impairment. Valsartan dosage: Level 1. During the same period patient was treated with NATEGLINIDE (Level 2) (View Nateglinide Review and Nateglinide Label ). Patient was hospitalized.

6507295-9 | Angiogram, Blood Creatine Phosphokinase Mb Increased, Chest Pain, Coronary Artery Occlusion, Disease Progression, Myocardial Infarction, Troponin T Increased
Patient was taking Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: angiogram, blood creatine phosphokinase mb increased, chest pain (What is chest pain?), coronary artery occlusion, disease progression, myocardial infarction, troponin t increased on Dec 16, 2009 from DENMARK Additional patient health information: Male patient , weighting 242.5 lb, was diagnosed with cardiovascular disorder and. Valsartan dosage: Level 1. During the same period patient was treated with NATEGLINIDE (Level 2) (View Nateglinide Review and Nateglinide Label ), SELO ZOK (View Selo-zok Review and Selo-zok Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6507283-2 | Dizziness, Electrocardiogram T Wave Abnormal, Flushing, Presyncope, Sensation Of Pressure, Vertigo Positional
Adverse event was reported on Dec 16, 2009 by a Male patient taking Valsartan (View Usage) (Dosage: Level 1) was diagnosed with cardiovascular disorder and. Location: UNITED KINGDOM , weighting 238.1 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), electrocardiogram t wave abnormal, flushing, presyncope, sensation of pressure, vertigo positional. During the same period patient was treated with NATEGLINIDE (Level 2) (View Nateglinide Review and Nateglinide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ). Patient was hospitalized.

6505216-6 | Anxiety, Dizziness, Hypertension, Nausea, Orthostatic Hypotension, Somnolence, Vertebrobasilar Insufficiency
on Dec 17, 2009 Female patient from ARGENTINA , weighting 162.0 lb, was diagnosed with glucose tolerance impaired, hypertension, anxiety (What is anxiety?) and was treated with Valsartan (View Usage). Patient had the following side effects: anxiety (What is anxiety?), dizziness (What is dizziness?), hypertension, nausea (What is nausea?), orthostatic hypotension, somnolence, vertebrobasilar insufficiency. Valsartan dosage: Level 1. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

6496735-X | Disorientation, Fall, Injury, Malaise, Urinary Retention
on Dec 02, 2009 Female patient from UNITED STATES , 87 years of age, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: disorientation, fall (What is fall?), injury, malaise, urinary retention. Valsartan dosage: Unk, Intravesical.

6471125-4 | Anxiety, Dizziness, Hypertension, Nausea, Orthostatic Hypotension, Somnolence, Vertebrobasilar Insufficiency
Patient was taking Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dizziness (What is dizziness?), hypertension, nausea (What is nausea?), orthostatic hypotension, somnolence, vertebrobasilar insufficiency on Nov 30, 2009 from ARGENTINA Additional patient health information: Female patient , weighting 162.0 lb, was diagnosed with glucose tolerance impaired, hypertension and. Valsartan dosage: Level 1. During the same period patient was treated with STARLIX (Level 1) (View Starlix Review and Starlix Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6469417-8 | Hyperkalaemia, Hypotension
Adverse event was reported on Dec 02, 2009 by a Male patient taking Valsartan (View Usage) (Dosage: 160 Mg Bid Po) was diagnosed with hypertension and. Location: UNITED STATES , 86 years of age, weighting 125.4 lb, Patient had the following side effects: hyperkalaemia, hypotension. Patient was hospitalized.

6460266-3 | Haematuria, Red Blood Cells Urine Positive
on Nov 16, 2009 Female patient from CHINA , 60 years of age, was diagnosed with hypertension and was treated with Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: haematuria, red blood cells urine positive. Valsartan dosage: 80 Mg, Qd.

6431426-2 | Acute Abdomen, Acute Coronary Syndrome, Anaemia, Angina Pectoris, Asthenia, Atrial Fibrillation, Carotid Artery Disease, Chest Pain, Chest Tube Insertion
on Nov 03, 2009 Male patient from ARGENTINA , weighting 189.4 lb, was diagnosed with cardiovascular disorder, glucose tolerance impaired and was treated with Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: acute abdomen, acute coronary syndrome, anaemia, angina pectoris, asthenia, atrial fibrillation (What is atrial fibrillation?), carotid artery disease (What is carotid artery disease?), chest pain (What is chest pain?), chest tube insertion. Valsartan dosage: Level 1. During the same period patient was treated with STARLIX (Level 1) (View Starlix Review and Starlix Label ). Patient was hospitalized.

6422947-7 | Aphonia, Pharyngeal Oedema, Rash
Patient was taking Valsartan (View Usage). Patient had the following side effects: aphonia, pharyngeal oedema, rash (What is rash?) on Oct 26, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 74 years of age, weighting 163.1 lb, was diagnosed with hypertension and. Valsartan dosage: 80 Mg, Unk.

6404580-6 | Acute Abdomen, Acute Coronary Syndrome, Anaemia, Angina Pectoris, Asthenia, Atrial Fibrillation, Carotid Artery Disease, Chest Pain, Chest Tube Insertion
Adverse event was reported on Oct 13, 2009 by a Male patient taking Valsartan (View Usage) (Dosage: Level 1) was diagnosed with cardiovascular disorder, glucose tolerance impaired and. Location: ARGENTINA , weighting 189.4 lb, After Valsartan was administered, patient had the following side effects: acute abdomen, acute coronary syndrome, anaemia, angina pectoris, asthenia, atrial fibrillation (What is atrial fibrillation?), carotid artery disease (What is carotid artery disease?), chest pain (What is chest pain?), chest tube insertion. During the same period patient was treated with STARLIX (Level 1) (View Starlix Review and Starlix Label ). Patient was hospitalized.

6392347-7 | Optic Ischaemic Neuropathy
on Sep 30, 2009 Female patient from SINGAPORE , 77 years of age, was diagnosed with hypertension and was treated with Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: optic ischaemic neuropathy. Valsartan dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ).

6385024-X | Cardiac Pacemaker Insertion, Loss Of Consciousness
on Sep 24, 2009 Male patient from AUSTRALIA , weighting 233.7 lb, was diagnosed with cardiovascular disorder, glucose tolerance impaired and was treated with Valsartan (View Usage). Patient had the following side effects: cardiac pacemaker insertion, loss of consciousness. Valsartan dosage: Level 1. During the same period patient was treated with STARLIX (Level 1) (View Starlix Review and Starlix Label ). Patient was hospitalized.

6378008-9 | Acute Abdomen, Acute Coronary Syndrome, Anaemia, Angina Pectoris, Asthenia, Atrial Fibrillation, Carotid Artery Disease, Chest Pain, Chest Tube Insertion
Patient was taking Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: acute abdomen, acute coronary syndrome, anaemia, angina pectoris, asthenia, atrial fibrillation (What is atrial fibrillation?), carotid artery disease (What is carotid artery disease?), chest pain (What is chest pain?), chest tube insertion on Sep 23, 2009 from ARGENTINA Additional patient health information: Male patient , weighting 189.4 lb, was diagnosed with cardiovascular disorder, glucose tolerance impaired and. Valsartan dosage: Level 1. During the same period patient was treated with STARLIX (Level 1) (View Starlix Review and Starlix Label ). Patient was hospitalized.

6366672-X | Acute Abdomen, Acute Coronary Syndrome, Anaemia, Angina Pectoris, Asthenia, Atrial Fibrillation, Carotid Artery Disease, Chest Pain, Chest Tube Insertion
Adverse event was reported on Sep 09, 2009 by a Male patient taking Valsartan (View Usage) (Dosage: Level 1) was diagnosed with cardiovascular disorder, glucose tolerance impaired and. Location: ARGENTINA , weighting 189.4 lb, Patient experienced the following unwanted or unexpected effects: acute abdomen, acute coronary syndrome, anaemia, angina pectoris, asthenia, atrial fibrillation (What is atrial fibrillation?), carotid artery disease (What is carotid artery disease?), chest pain (What is chest pain?), chest tube insertion. During the same period patient was treated with STARLIX (Level 1) (View Starlix Review and Starlix Label ). Patient was hospitalized.

6366624-X | Acute Abdomen, Acute Coronary Syndrome, Anaemia, Angina Pectoris, Asthenia, Atrial Fibrillation, Carotid Artery Disease, Chest Pain, Chest Tube Insertion
on Sep 09, 2009 Male patient from ARGENTINA , weighting 189.4 lb, was diagnosed with cardiovascular disorder, glucose tolerance impaired and was treated with Valsartan (View Usage). Patient had the following side effects: acute abdomen, acute coronary syndrome, anaemia, angina pectoris, asthenia, atrial fibrillation (What is atrial fibrillation?), carotid artery disease (What is carotid artery disease?), chest pain (What is chest pain?), chest tube insertion. Valsartan dosage: Level 1. During the same period patient was treated with STARLIX (Level 1) (View Starlix Review and Starlix Label ). Patient was hospitalized.

6359229-8 | Acute Coronary Syndrome, Anaemia, Angina Pectoris, Asthenia, Carotid Artery Disease, Chest Pain, Colectomy, Dizziness
on Sep 09, 2009 Male patient from ARGENTINA , weighting 189.4 lb, was diagnosed with cardiovascular disorder, glucose tolerance impaired and was treated with Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: acute coronary syndrome, anaemia, angina pectoris, asthenia, carotid artery disease (What is carotid artery disease?), chest pain (What is chest pain?), colectomy, dizziness (What is dizziness?). Valsartan dosage: Level 1. During the same period patient was treated with STARLIX (Level 1) (View Starlix Review and Starlix Label ). Patient was hospitalized.

6344976-4 | Completed Suicide
Patient was taking Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide on Aug 26, 2009 from UNITED STATES Additional patient health information: Male patient , 51 years of age, . Valsartan dosage: . During the same period patient was treated with FINASTERIDE (View Finasteride Review and Finasteride Label ), DIPYRIDAMOLE/ASPIRIN (View Dipyridamole/aspirin Review and Dipyridamole/aspirin Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), NITRATE (View Nitrate Review and Nitrate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), VYTORIN (View Vytorin Review and Vytorin Label ), METOLAZONE (View Metolazone Review and Metolazone Label ).

6300153-4 | Acute Coronary Syndrome, Anaemia, Angina Pectoris, Asthenia, Carotid Artery Disease, Chest Pain, Colectomy, Dizziness, Dyspnoea
Adverse event was reported on Jul 30, 2009 by a Male patient taking Valsartan (View Usage) (Dosage: Level 1) was diagnosed with cardiovascular disorder, glucose tolerance impaired and. Location: ARGENTINA , weighting 189.4 lb, Patient had the following side effects: acute coronary syndrome, anaemia, angina pectoris, asthenia, carotid artery disease (What is carotid artery disease?), chest pain (What is chest pain?), colectomy, dizziness (What is dizziness?), dyspnoea. During the same period patient was treated with STARLIX (Level 1) (View Starlix Review and Starlix Label ). Patient was hospitalized.

6283266-5 | Blood Creatinine Increased, Blood Urea Increased, Confusional State, Mental Status Changes
on Jul 22, 2009 Male patient from UNITED STATES , 59 years of age, was diagnosed with cardiac failure chronic and was treated with Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: blood creatinine increased, blood urea increased, confusional state, mental status changes. Valsartan dosage: 20 Mg Bid Po. Patient was hospitalized.

6265496-1 | Arthritis, Cough, Hilar Lymphadenopathy, Rash Macular, Sarcoidosis, Skin Plaque
on Jun 29, 2009 Male patient from SPAIN , 49 years of age, was diagnosed with hypertension and was treated with Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), cough, hilar lymphadenopathy, rash macular, sarcoidosis, skin plaque. Valsartan dosage: 160 Mg Per Day.

6263770-6 | Asthma, Blood Glucose Increased, Diabetes Mellitus Inadequate Control, Dyspnoea, Joint Swelling, Left Ventricular Failure
Patient was taking Valsartan (View Usage). Patient had the following side effects: asthma (What is asthma?), blood glucose increased, diabetes mellitus inadequate control, dyspnoea, joint swelling, left ventricular failure on Jul 01, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 68 years of age, was diagnosed with hypertension and. Valsartan dosage: 40mg. During the same period patient was treated with RAMIPRIL (2.5mg) (View Ramipril Review and Ramipril Label ).

6255123-1 | Aspiration, Hiccups, Loss Of Consciousness, Pneumonia, Respiratory Rate Increased, Sedation
Adverse event was reported on Jun 19, 2009 by a Male patient taking Valsartan (View Usage) (Dosage: Unk, Unk) was diagnosed with hiccups and. Location: JAPAN , 75 years of age, After Valsartan was administered, patient had the following side effects: aspiration, hiccups, loss of consciousness, pneumonia (What is pneumonia?), respiratory rate increased, sedation. During the same period patient was treated with AMLODIPINE (Unk, Unk) (View Amlodipine Review and Amlodipine Label ), CLONAZEPAM (1 Mg) (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

6252629-6 | Hyperkalaemia
on Jun 29, 2009 Male patient from UNITED STATES , 74 years of age, was diagnosed with cardiac failure congestive and was treated with Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia. Valsartan dosage: 320 Mg Every Day Po. Patient was hospitalized.

6245459-2 | Granuloma Skin, Hyperkeratosis, Lichen Planus, Lymphocytic Infiltration, Pigmentation Disorder, Rash Papular, Rash Pruritic, Skin Disorder
on Jun 16, 2009 Female patient from TURKEY , 46 years of age, was diagnosed with hypertension and was treated with Valsartan (View Usage). Patient had the following side effects: granuloma skin, hyperkeratosis, lichen planus, lymphocytic infiltration, pigmentation disorder, rash papular, rash pruritic, skin disorder. Valsartan dosage: .

6245454-3 | Lichenoid Keratosis, Rash Papular, Rash Pruritic, Skin Disorder, Skin Hyperpigmentation
Patient was taking Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: lichenoid keratosis, rash papular, rash pruritic, skin disorder, skin hyperpigmentation on Jun 16, 2009 from TURKEY Additional patient health information: Male patient , 57 years of age, . Valsartan dosage: . During the same period patient was treated with FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ).

6216712-3 | Bradycardia, Renal Failure Acute
Adverse event was reported on Jun 03, 2009 by a Male patient taking Valsartan (View Usage) (Dosage: 80 Mg Every Day Po) . Location: UNITED STATES , 82 years of age, weighting 187.4 lb, Patient experienced the following unwanted or unexpected effects: bradycardia, renal failure acute.

6199838-2 | Blood Creatinine Increased, Blood Urea Increased
on May 20, 2009 Male patient from UNITED STATES , 68 years of age, weighting 281.0 lb, was diagnosed with hypertension and was treated with Valsartan (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased. Valsartan dosage: 320mg Every Day Po. During the same period patient was treated with HYDROCHLOROTHIAZIDE (50mg Every Day Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6177919-7 | Angioedema
on May 01, 2009 Male patient from UNITED STATES , 48 years of age, weighting 304.9 lb, was diagnosed with hypertension and was treated with Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: angioedema. Valsartan dosage: 320 Mg Every Day Po. Patient was hospitalized.

6177078-0 | Headache
Patient was taking Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?) on Apr 30, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 210.4 lb, . Valsartan dosage: 160mg Tablet 160 Mg Qd Oral. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BUTALBITAL+ASA+CAFFEINE (BUTALBITAL+ASA+CAFFFEINE) (View Butalbital+asa+caffeine (butalbital+asa+cafffeine) Review and Butalbital+asa+caffeine (butalbital+asa+cafffeine) Label ), EPIPEN (EPINEPHRINE AUTOINJECTOR) (View Epipen (epinephrine Autoinjector) Review and Epipen (epinephrine Autoinjector) Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MAXZIDE 25 (TRIAMTERENE 37.5 MG/HYDROCHLOROTHIAZIDE 25 MG TAB) (View Maxzide-25 (triamterene 37.5 Mg/hydrochlorothiazide 25 Mg Tab) Review and Maxzide-25 (triamterene 37.5 Mg/hydrochlorothiazide 25 Mg Tab) Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ).

6168229-2 | Disorientation, Hepatic Cirrhosis, Hypoprothrombinaemia, Jaundice, Portal Hypertension, Toxoplasma Serology Positive
Adverse event was reported on Apr 22, 2009 by a Male patient taking Valsartan (View Usage) (Dosage: 160 Mg, Qd) was diagnosed with hypertension and. Location: SPAIN , 67 years of age, Patient had the following side effects: disorientation, hepatic cirrhosis, hypoprothrombinaemia, jaundice (What is jaundice?), portal hypertension, toxoplasma serology positive. During the same period patient was treated with SUTRIL (2.5 Mg, Qd) (View Sutril Review and Sutril Label ). Patient was hospitalized.

6154880-2 | Catheterisation Cardiac, Scintigraphy, Stent Placement, Stress
on Apr 03, 2009 Male patient from BRAZIL , weighting 145.5 lb, was treated with Valsartan (View Usage). After Valsartan was administered, patient had the following side effects: catheterisation cardiac, scintigraphy, stent placement, stress (What is stress?). Valsartan dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6107557-3 | Mastication Disorder, Rash, Skin Disorder, Tongue Oedema
on Feb 25, 2009 Female patient from SPAIN , 71 years of age, was treated with Valsartan (View Usage). Patient experienced the following unwanted or unexpected effects: mastication disorder, rash (What is rash?), skin disorder, tongue oedema. Valsartan dosage: 320 Mg. During the same period patient was treated with EUTIROX (View Eutirox Review and Eutirox Label ), VERAPAMIL HCL (240 Mg) (View Verapamil Hcl Review and Verapamil Hcl Label ), FUROSEMIDE (10 Mg) (View Furosemide Review and Furosemide Label ), SIMVASTATIN (10 Mg) (View Simvastatin Review and Simvastatin Label ).

6105113-4 | Headache
Patient was taking Valsartan (View Usage). Patient had the following side effects: headache (What is headache?) on Mar 04, 2009 from UNITED STATES Additional patient health information: Male patient , 57 years of age, weighting 206.0 lb, was diagnosed with hypertension and. Valsartan dosage: 80 Mg Every Day Po.